225 related articles for article (PubMed ID: 26160836)
1. Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific.
Woolston A; Sintupisut N; Lu TP; Lai LC; Tsai MH; Chuang EY; Yeang CH
Oncotarget; 2015 Aug; 6(23):19483-99. PubMed ID: 26160836
[TBL] [Abstract][Full Text] [Related]
2. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
3. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.
Truong T; Hung RJ; Amos CI; Wu X; Bickeböller H; Rosenberger A; Sauter W; Illig T; Wichmann HE; Risch A; Dienemann H; Kaaks R; Yang P; Jiang R; Wiencke JK; Wrensch M; Hansen H; Kelsey KT; Matsuo K; Tajima K; Schwartz AG; Wenzlaff A; Seow A; Ying C; Staratschek-Jox A; Nürnberg P; Stoelben E; Wolf J; Lazarus P; Muscat JE; Gallagher CJ; Zienolddiny S; Haugen A; van der Heijden HF; Kiemeney LA; Isla D; Mayordomo JI; Rafnar T; Stefansson K; Zhang ZF; Chang SC; Kim JH; Hong YC; Duell EJ; Andrew AS; Lejbkowicz F; Rennert G; Müller H; Brenner H; Le Marchand L; Benhamou S; Bouchardy C; Teare MD; Xue X; McLaughlin J; Liu G; McKay JD; Brennan P; Spitz MR
J Natl Cancer Inst; 2010 Jul; 102(13):959-71. PubMed ID: 20548021
[TBL] [Abstract][Full Text] [Related]
4. The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.
Lo FY; Chang JW; Chang IS; Chen YJ; Hsu HS; Huang SF; Tsai FY; Jiang SS; Kanteti R; Nandi S; Salgia R; Wang YC
BMC Cancer; 2012 Jun; 12():235. PubMed ID: 22691236
[TBL] [Abstract][Full Text] [Related]
5. SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women.
Okano Y; Nezu U; Enokida Y; Lee MT; Kinoshita H; Lezhava A; Hayashizaki Y; Morita S; Taguri M; Ichikawa Y; Kaneko T; Natsumeda Y; Yokose T; Nakayama H; Miyagi Y; Ishikawa T
PLoS One; 2013; 8(9):e73794. PubMed ID: 24040073
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiles specific to patient ethnicity in lung adenocarcinoma.
Broët P; Dalmasso C; Tan EH; Alifano M; Zhang S; Wu J; Lee MH; Régnard JF; Lim D; Koong HN; Agasthian T; Miller LD; Lim E; Camilleri-Broët S; Tan P
Clin Cancer Res; 2011 Jun; 17(11):3542-50. PubMed ID: 21521776
[TBL] [Abstract][Full Text] [Related]
7. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlation in Chinese patients with pulmonary mixed type adenocarcinoma: Relationship between histologic subtypes, TITF-1/SP-A expressions and EGFR mutations.
Jie-Liu ; Li XY; Zhao YQ; Liu RQ; Zhang JB; Ma J; Chen LJ; Hu XF
Pathol Res Pract; 2014 Mar; 210(3):176-81. PubMed ID: 24370340
[TBL] [Abstract][Full Text] [Related]
9. Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.
Cserepes M; Ostoros G; Lohinai Z; Raso E; Barbai T; Timar J; Rozsas A; Moldvay J; Kovalszky I; Fabian K; Gyulai M; Ghanim B; Laszlo V; Klikovits T; Hoda MA; Grusch M; Berger W; Klepetko W; Hegedus B; Dome B
Eur J Cancer; 2014 Jul; 50(10):1819-1828. PubMed ID: 24768329
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
11. Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS wild-type lung adenocarcinoma reveals gene signatures associated with patient outcome.
Planck M; Isaksson S; Veerla S; Staaf J
Clin Cancer Res; 2013 Sep; 19(18):5116-26. PubMed ID: 23938291
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method.
Cai Q; He B; Xie H; Zhang P; Peng X; Zhang Y; Zhao Z; Wang X
Cancer Med; 2020 Oct; 9(20):7488-7502. PubMed ID: 32860318
[TBL] [Abstract][Full Text] [Related]
13. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.
Zhou W; Christiani DC
Chin J Cancer; 2011 May; 30(5):287-92. PubMed ID: 21527061
[TBL] [Abstract][Full Text] [Related]
14. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
15. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
17. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Dai D; Shi R; Han S; Jin H; Wang X
Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
[TBL] [Abstract][Full Text] [Related]
18. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
[TBL] [Abstract][Full Text] [Related]
19. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
Zhou X; Wen W; Shan X; Zhu W; Xu J; Guo R; Cheng W; Wang F; Qi LW; Chen Y; Huang Z; Wang T; Zhu D; Liu P; Shu Y
Oncotarget; 2017 Jan; 8(4):6513-6525. PubMed ID: 28036284
[TBL] [Abstract][Full Text] [Related]
20. Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
Sato S; Nagahashi M; Koike T; Ichikawa H; Shimada Y; Watanabe S; Kikuchi T; Takada K; Nakanishi R; Oki E; Okamoto T; Akazawa K; Lyle S; Ling Y; Takabe K; Okuda S; Wakai T; Tsuchida M
Sci Rep; 2018 Jan; 8(1):1005. PubMed ID: 29343775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
